首页> 美国卫生研究院文献>Medicina >Incidence of Iron Deficiency and the Role of Intravenous Iron Use in Perioperative Periods
【2h】

Incidence of Iron Deficiency and the Role of Intravenous Iron Use in Perioperative Periods

机译:铁缺乏的发病率和静脉注射铁在围手术期的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Iron deficiency is a major problem in worldwide populations, being more alarming in surgical patients. In the presence of absolute iron deficiency (depletion of body iron), functional iron deficiency (during intense bone marrow stimulation by endogenous or exogenous factors), or iron sequestration (acute or chronic inflammatory conditions), iron-restricted erythropoiesis can develop. This systemic review was conducted to draw attention to the delicate problem of perioperative anemia, and to provide solutions to optimize the management of anemic surgical patients. Systemic reviews and meta-analyses, clinical studies and trials, case reports and international guidelines were studied, from a database of 50 articles. Bone marrow biopsy, serum ferritin levels, transferrin saturation, the mean corpuscular volume, and mean corpuscular hemoglobin concentration were used in the diagnosis of iron deficiency. There are various intravenous iron formulations, with different pharmacological profiles used for restoring iron. In surgical patients, anemia is an independent risk factor for morbidity and mortality. Therefore, anemia correction should be rapid, with parenteral iron formulations—the oral ones—being inefficient. Various studies showed the safety and efficacy of parenteral iron formulations in correcting hemoglobin levels and decreasing the blood transfusion rate, the overall mortality, the postoperative infections incidence, hospitalization days, and the general costs.
机译:铁缺乏是全球种群的一个主要问题,在手术患者中更加惊人。在存在绝对的缺铁(枯竭的身体铁)中,功能性释铁缺乏(在内源性或外源性因素的强烈骨髓刺激期间),或铁螯合(急性或慢性炎症条件),铁限制性的促红细胞生成可以发展。进行了这种全身审查,引起了对围手术期贫血的微妙问题,并提供了优化贫血患者的管理的解决方案。从50篇文章的数据库中研究了系统性评价,临床研究和审判,案例报告和国际指南。骨髓活检,血清铁蛋白水平,转移素饱和度,平均碎石体积和平均血小杂血红蛋白浓度用于诊断缺铁。有各种静脉注射铁制剂,具有用于恢复铁的不同药理学型材。在手术患者中,贫血是发病率和死亡率的独立危险因素。因此,贫血矫正应该是快速的,肠胃外铁制剂 - 口服效率低效。各种研究表明,肠胃外铁制剂在校正血红蛋白水平中的安全性和有效性,降低了血液输血率,整体死亡率,术后感染发生,住院日期和一般成本。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号